In this sense, Razeghian‐Jahromi et al. also emphasized the importance of the dichotomous role of ACE2 regulation on the COVID‐19 progression and subsequent SARS‐CoV‐2‐induced CV complications, particularly in positive patients with heart failure (HF).5 Here, ACE2 is linked to COVID-19.